307 related articles for article (PubMed ID: 2472449)
1. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
Tomkinson BE; Maziarz R; Sullivan JL
J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
[TBL] [Abstract][Full Text] [Related]
2. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Strang G; Rickinson AB
Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
Quinones RR; Segal DM; Henkart P; Perez P; Gress RE
J Immunol; 1989 Apr; 142(7):2200-6. PubMed ID: 2466891
[TBL] [Abstract][Full Text] [Related]
4. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
Darrow TL; Slingluff CL; Seigler HF
J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
[TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
6. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
Koide J; Rivas A; Engleman EG
J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
[TBL] [Abstract][Full Text] [Related]
7. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
[TBL] [Abstract][Full Text] [Related]
8. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
9. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
[TBL] [Abstract][Full Text] [Related]
10. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
11. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
12. Temperature requirements and kinetics of T cell signaling. Velocity of triggering correlates with functional effects of anti-CD3 mAb.
Abdi K; Reed ML; Mentzer SJ; Herrmann SH
J Immunol; 1989 May; 142(9):2971-80. PubMed ID: 2468707
[TBL] [Abstract][Full Text] [Related]
13. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
14. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
15. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
Platsoucas CD
Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
[TBL] [Abstract][Full Text] [Related]
16. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
[TBL] [Abstract][Full Text] [Related]
17. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
[TBL] [Abstract][Full Text] [Related]
18. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
Bonavida B; Katz J
J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
[TBL] [Abstract][Full Text] [Related]
19. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
20. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
